Approximately 50% of Caucasians with or without PWS and regardless of PWS genetic subtype have a GHR gene (exon-3 deletion) polymorphism which is associated with an increased response to growth hormone therapy with growth acceleration [54,55,56]. Here, GH1 is linked to Prader-Willi syndrome.